New Cosmetic Formulation for the Treatment of Mild to Moderate Infantile Atopic Dermatitis

Children
doi 10.3390/children6020017
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Atopic Dermatitis: Infantile Phase

Klinicheskaya Dermatologiya i Venerologiya
DermatologyInfectious Diseases
2018English

Evaluation of a Pseudoceramide Moisturizer in Patients With Mild-To-Moderate Atopic Dermatitis

Dermatology and Therapy
Dermatology
2014English

Efficacy and Safety of Dupilumab for the Treatment of Moderate-To-Severe Atopic Dermatitis in Adults

Oncotarget
Oncology
2017English

Dupilumab for the Treatment of Atopic Dermatitis

Prescriber
Pharmacology
2018English

Long-Term Safety of Crisaborole Ointment 2% in Children and Adults With Mild-To-Moderate Atopic Dermatitis

Pediatrics
Child HealthPediatricsPerinatology
2018English

Novel Therapeutic Approach With PAC ‐14028 Cream, a TRPV 1 Antagonist, for Patients With Mild‐to‐moderate Atopic Dermatitis

British Journal of Dermatology
DermatologyMedicine
2019English

A Mild Topical Steroid Leads to Progressive Anti-Inflammatory Effects in the Skin of Patients With Moderate-To-Severe Atopic Dermatitis

Journal of Allergy and Clinical Immunology
AllergyImmunology
2016English

Nonpharmacological Treatment Options for Mild to Moderate Depression

Advances in Pulmonary Hypertension
2011English

Effect of Moderate to Severe Atopic Dermatitis on the Prognosis of Egg Allergy Resolution

Asian Pacific Journal of Allergy and Immunology
MedicineAllergyImmunology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy